Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
Anatara Lifesciences Advances Trials and Raises Capital
Anatara Lifesciences Ltd (AU:ANR) has released an update. Anatara Lifesciences is advancing its Phase II trial for GaRP in treating Irritable ...
malaymail12h
Hold my Ozempic: British Vogue editor sounds alarm over comeback of ultra-thin models
LONDON, Nov 14 — The editorial director of British Vogue magazine on Wednesday said she was worried about the return of thin ...
Medscape22h
Effect of Fondaparinux Prophylaxis on Anti-factor Xa Concentrations in Patients With Morbid Obesity
Obesity is associated with an increased risk of VTE, and it has been postulated that standard prophylactic LMWH doses may be insufficient to prevent VTE or achieve suggested anti-factor Xa target ...